Listar por tema "LEISHMANIASIS MUCOCUTÁNEA"
Mostrando ítems 1-8 de 8
-
A Randomized Trial of Amphotericin B alone or in combination with Itraconazole in the treatment of mucocutaneous Leishmaniasis
(Mem. Inst. Oswaldo Cruz, 1995)A randomized trial of amphotericin B (AB) alone and in combination with oral itraconazole (IZ) is carried out in two groups of 10 mucocutaneous leishmaniasis patients from Bolivia and Perú. AB+IZ combination is no better ... -
Clinical healing of antimony-resistant cutaneous or mucocutaneous Leishmaniasis following the combined administration of interferon-γ and pentavalent antimonials compounds
(Transactions of The Royal Society of Tropical Medicine and Hygiene, 1994)Abstract. In an open trial, longer courses of pentavalent antimonials (Sbˇ) at sub-optimal doses (10 mg/kg body weight), in association with recombinant human interferon-γ (IFN-γ) (100 µg/m2 of body surface area) were ... -
Electrocardiographic alterations during treatment of mucocutaneous leishmaniasis with meglumine antimoniate and allopurinol
(Transantions of The Royal Society of Tropical Medicine and Hygiene, 1992)Abstract. The electrocardiographic (ECG) changes in Bolivian patients with mucocutaneous leishmaniasis, treated with meglumine antimoniate and allopurinol, were evaluated. Electric changes due to the antimonial compound ... -
Nasal polyp associated with mucocutaneous leishmaniasis. Report of two cases
(Eur J Dermatol, 1994)Mucocutaneous leishmaniosis (MCL) can manifest in different forms and affects skin as well as mucosae. Nasal polyps are rare. We report the cases of two male patients with nasal polyps. One polyps. One of them with cutaneous ... -
Particularités épidémiologiquez, cliniques et biologigues de la Leishmaniose cutanéo-muqueuse en Bolivia d'après un échantillon de 221 malades
(Bull. Soc. Path Ex., 1993)Résumé. Les auteurs présentent les aspects cliniques, biologiquez et épidémiologigues de la leishmaniose cutanéo-muqueuse, d’après un échantillon de 221 cas (136 leishmanioses cutanées et 85 leishmanioses muqueuses) observés ... -
Risk factors for onset of cutaneous and mucocutaneous Leishmaniasis in Bolivia
(American Journal Tropical Medicine and Hygiene, 1997)Abstract. A survival analysis was performed on data from an endemic area of Bolivia where two populations, natives and highland migrants, were living, to investigate risk factors for onset of cutaneous leishmaniasis (CL) ... -
Rural campaign to diagnose and treat mucocutaneous leishmaniasis in Bolivia
(Bulletin of the World Health Organization, 1995)Abstract. Mucocutaneous leishmaniasis (MCL) is endemic in the tropical Amazonian lowlands of Bolivia, an area that regularly receives influxes of migratory populations. In these new agricultural development areas, a ... -
Specific IgE antibodies to Leishmania braziliensis in patients with mucocutaneous leishmaniasis
(Ann. Immunol., 1983)Abstract. A total of 116 sera of patients suffering from South American mucocutaneous leishmaniasis were analysed using the RAST (L. braziliensis-specific) and RIST techniques. Results of total and specific IgE levels ...